Compass Pharma Services is targeting contract drug developers and clinical research firms with a new microfilling offering that, it claims, helps reduce waste and may even make excipients unnecessary in some drugs.
The quality control systems in place at Isreali drugmaker Taro Pharmaceutical’s manufacturing facility in Ontario, Canada are the subject of a US FDA warning letter following an inspection carried out last year.
New research suggests that deuteration, the replacement of hydrogen atoms with heavier forms, can alter an API's crystallisation properties and help drugmakers make better more effective drugs.
Millipore hopes its $23m (€18m) swoop for Guava Technologies will draw attention away from the underperformance of its bioprocess division, revenue from which fell 6 per cent in Q4 to $214m (€165m) and 2 per cent for 2008 overall.
Authentication and track and trace methods, like pedigree, should be combined to provide layers of protection against counterfeit drugs according to XStream Systems’ CEO Brian Mayo.
DSM is evaluating Micronit Microfluidics’ new microreactor, which has been developed to perform industrial scale fluid reactions of fine chemicals in a continuous process.
Haupt Pharma has acquired Pfizer’s production facility in Latina, Italy, which moves the contract manufacturer into antibiotics and allows it to provide additional services to clients.
Industrial processing giant Pall is stepping up global promotion efforts for its Allegro platform as the market for single-use drug manufacturing options, estimated to be worth around $400m (€308m), continues to expand.
Falling API sales and “an unprecedented negative economic environment” have forced Perrigo to cut its fiscal 2009 profit forecast and sent stock plummeting by 20 per cent.
US contract developer Xcelience has added small-scale batch production capability to its repertoire of good manufacturing proactice (GMP) accredited production services in a bid to attract drug firms working with small quantities of API.
Almac Sciences, part of global contracting group Almac, chose this year’s Informex in San Francisco, US to showcase its solid state chemistry (SSC) services to drugmakers in North America.
Canadian contract manufacturing organisation PharmEng International, which has been hit by dwindling cash reserves in recent months, got a boost last week when its subsidiary Keata Pharma was awarded a C$3m research grant.
Thermo Fisher Scientific hopes that the web functionality offered by the latest generation of its Darwin LIMS system will help it become the natural selection for drug makers seeking an all-in-one QA solution.
D3 Technology hopes its new SERS-based cleaning verification test, that follows FDA guidelines, will prove attractive to drugmakers looking to expedite the cleaning process and cut downtime between production runs.
ABB has launched its latest process analytical technology (PAT) software xPAT, which it claims will help companies implement quality by design (QbD) through a products entire lifecycle.
OutsourcingPharna.com presents a round-up of recent contracts awarded to contract development and manufacturing services companies – and finds a lot of activity in the biomanufacturing sector.
Active pharmaceutical ingredient (API) manufacturer Ash Stevens Inc has been accredited under an industry-backed scheme that certifies companies whose processes are environmentally sound and safe.
Indian company Neuland Laboratories has launched a push into the peptide manufacturing sector to expand the range of active pharmaceutical ingredients (APIs) it can offer to customers.
We spoke with Martijn Eijkenboom, president of NAF & VSM, to discuss his companies’ entry into the market for pre-washed vials, ampoules and test tubes.
A new report suggests the large numbers of fake drugs produced in China could drive CMO customers away and see Central and Eastern Europe (CEE) emerge as a contract manufacturing hotbed.
The US Food and Drug Administration (FDA) has issued a draft guidance on the measures pharmaceutical and other manufacturers should take to make sure imported FDA-regulated products are in line with federal statutes and regulations.
Lonza is spending $26m to expand capacity at its facility in Walkersville, Maryland, US as regulatory progress made with Osiris’ Prochymal looks set to kick start the era of cell therapies.
US contract manufacturer Ash Stevens Inc has upgraded its active pharmaceutical ingredient (API) facility in Riverview, Michigan, with new equipment for parallel synthesis and calorimetry.
In the latest part of its “beyond our borders” scheme, the US FDA is asking drugmakers to volunteer supply chain information for drugs and APIs sourced outside the USA.
US biotechnology company Cel-Sci is hoping to offer contract manufacturing to pharmaceutical partners from its new facility in Baltimore, as it tries to raise money to support the clinical development of its cancer immunotherapy Multikine.
Despite criticism in certain quarters, joint GMP inspections represent the best use of resources in an increasingly globalised market, according to the EMEA.
There is still no formal offer on the table for Canadian contract manufacturer Patheon from JLL Patheon Holdings, an investment group which currently owns around 29 per cent of the firm.
Akrimax Pharmaceuticals, which entered the contract manufacturing sector via the purchase of a Wyeth facility in New York, US, a year ago - has signed its first third-party agreement.
Since its inauguration last year, IPEC China has been working to improve the quality of excipient manufacturing in the country. in-PharmaTechnologist spoke with organisation president Nevin Cheng about the steps the body has taken so far and what it will...
The FDA has established its first permanent presence in Latin America by opening an office in Costa Rica as part of “Beyond Our Borders Initiative”, which has also seen the agency set up three sites in China.
US-based BioReliance has won the contract to supply bulk adenovirus for several live oral vaccines being produced by Barr Pharmaceutical’s Duramed subsidiary.
Actavis Totowa, part of Icelandic generics group Actavis, has agreed to stop selling drugs made at its facilities in New Jersey, US until the plants are made fully compliant with the FDA’s GMP guidelines.
Two contract manufacturing organisations PrimaPharm have been cited by the US Food and Drug Administration for not adhering to Good Manufacturing Practice standards.
Recipharm hopes that its new tablet and capsule manufacturing facility in Fontaine-Les-Dijon, France, which significantly expands its dry powder production capacity, will help it broaden its European client base.
US drugmaker and contract manufacturer Peregrine narrowed its losses in the second fiscal quarter ending October 31, as a result of cost-cutting measures.
Healthcare products company William Ransom & Son has finally published its financial results for the year ended March 31, 2008, and provided an update on efforts to turn around the troubled business.
Contract development and manufacturing company Patheon received an unsolicited takeover bid from private equity firm JLL Partners ahead of reporting a return to profit in its fiscal fourth quarter results.
AstraZeneca has signed a five year deal with Infosys Technologies for “end-to-end” application maintenance services in areas such as manufacturing, supply chain, finance, human resources and other corporate functions.
Portuguese contract manufacturer Hovione has emerged as the buyer for Pfizer’s production plant in Cork, Ireland, which was put on the block last year.
The timely identification of contaminants in pharmaceutical manufacture can be critical to avoiding costly delays. While it is relatively straightforward to establish the composition of a contaminating particle, determining its origin in the manufacturing...
Quadro Engineering has entered into a partnership to distribute Micro-Macinazione’s Jet-Mill products in the Americas, as well as launching its own API sifter.
The European Union’s long-awaited reform of pharmaceutical regulations known as the ‘pharmaceutical package’ was unveiled yesterday after months of consultation and debate.
GlaxoSmithKline has gone into partnership with Indian contract manufacturing and development services company Kemwell to set up an R&D facility aimed at developing new oral healthcare products.
Pall Life Sciences has launched its Allegro 3D biocontainers, which have been designed to improve the performance of the company’s large-scale, single use manufacturing systems.
One of Actavis’ Bulgarian production facilities is being bought out by the management, which will provide contract manufacturing services to the generic maker and other companies.
Demand for pharmaceutical manufacturing grade water in Europe shows no sign of drying up, according to a new study by industry analysts Frost & Sullivan.
Virginia’s Waste Control Board has challenged Merck to create different ways of achieving compliance with 2011 environmental standards, according to the Rocktown Weekly that is based in the state.
